UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 28, 2026
Navient Holdings, Inc.
(Exact name of Registrant as Specified in Its Charter)
Delaware 001-36228 42-4701395
(State... (continue reading...)
The following is a summary of the terms of the notes offered by the preliminary pricing supplement hyperlinked below. Index Overview The MerQube US Large - Cap Vol Advantage Index (the “Index”) attempts to provide a dynamic rules - based exposure to an unfunded rol ling position in E - Mini ® S&P 500 ® futures (the “Futures Contracts”), which reference the S&P 500 ® Index (the “Constituent”), while targeting a level of implied volatility, with a maximum exposure... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K FTAI Aviation Ltd. For: Oct 29
-
Form 10-Q ESCALADE INC For: Sep 30
-
Form 6-K CEMENTOS PACASMAYO SAA For: Oct 28
-
Form 6-K Neo-Concept Internationa For: Oct 29
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 6-K ASE Technology Holding For: Oct 29
-
Form SCHEDULE 13D/A Cloopen Group Holding Filed by: TB Alternative Assets Ltd.
-
Form 6-K AMBEV S.A. For: Dec 31
-
Form FWP JPMorgan Chase Financial Filed by: JPMorgan Chase Financial Co. LLC
-
Form 6-K AMBEV S.A. For: Dec 31
-
Form 6-K KB Financial Group Inc. For: Oct 29
-
Form FWP JPMORGAN CHASE & CO Filed by: JPMORGAN CHASE & CO
-
Form 4 Sea Ltd For: Oct 28 Filed by: Chen Jingye
-
Form 8-K Forbright, Inc. For: Oct 29
-
Form 6-K KB Financial Group Inc. For: Oct 29
-
Form D Future Health Holdings
-
Form 6-K HUTCHMED (China) Ltd For: Oct 29
-
Form S-4/A Trump Media & Technology
-
Form 6-K ASE Technology Holding For: Oct 29
-
Form 6-K Resolution Minerals Ltd For: Oct 29
-
Form 8-K Proto Labs Inc For: Oct 29
-
Form 6-K AMBEV S.A. For: Sep 30
-
Form 10-Q COHU INC For: Sep 26
-
Form 6-K Chilwa Minerals Ltd For: Oct 29
-
Form 6-K KB Financial Group Inc. For: Oct 29
-
Form SCHEDULE 13G/A Arcturus Therapeutics Filed by: Sumitomo Mitsui Trust Group, Inc.
-
Form SCHEDULE 13G/A MIZUHO FINANCIAL GROUP Filed by: Sumitomo Mitsui Trust Group, Inc.
-
Form 13F-NT Amova Asset Management For: Sep 30
-
Form 13F-NT Sumitomo Mitsui Trust For: Sep 30
-
Form 13F-HR Sumitomo Mitsui Trust For: Sep 30
-
Form 13F-NT SUMITOMO MITSUI TRUST For: Sep 30
-
Form 13F-NT AHAM Asset Management For: Sep 30
-
Form 13F-NT Amova Asset Management For: Sep 30
-
Form 13F-NT Amova Asset Management For: Sep 30
-
Form SCHEDULE 13G/A uCloudlink Group Inc. Filed by: China International Capital Corp (International) Ltd
-
Form 6-K ING GROEP NV For: Oct 29
-
Form 6-K ING GROEP NV For: Oct 29
-
Form 6-K Addex Therapeutics Ltd. For: Oct 29
-
Form 6-K Magnum Ice Cream Co N.V. For: Oct 29
-
Form 8-K ESCALADE INC For: Oct 27
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 6-K MOLECULAR PARTNERS AG For: Sep 30
-
Form 8-K L3HARRIS TECHNOLOGIES, For: Oct 29
-
Form 6-K AMBEV S.A. For: Sep 30
-
Form 425 K&F GROWTH ACQUISITION Filed by: K&F GROWTH ACQUISITION CORP. II
-
Form 4 Trident Digital Tech For: Oct 28 Filed by: HAIYAN HUANG
-
Form 4 Sea Ltd For: Oct 27 Filed by: Ye Gang
-
Form EFFECT Acumen Pharmaceuticals,
-
Form EFFECT AVIVA PLC
-
Form EFFECT ALPHA MODUS HOLDINGS,


